Biocon has received its first generic formulation approval in Europe to launch Rosuvastatin calcium tablets in several European countries. The product will be produced in strengths of Rosuvastatin Calcium 5 mg, 10 mg, 20 mg and 40 mg tablets, a generic equivalent of Crestor tablets, indicated for hyperlipidemia or mixed dyslipidemia.
Company Profile : Biocon Ltd
Leave a Reply